Worldwide Branding Recognizes DrugDev’s Sherri Miller for Finance Management Excellence

By
The potential for groundbreaking NASH therapies has generated excitement among investors and larger drugmakers, with behemoths like Gilead Sciences Inc. and Novo Nordisk A/S also pursuing treatments. (MONTCO.Today file photo).

Sherri Miller, DrugDev‘s Vice drugdevPresident of Finance and Accounting, has been recognized by Worldwide Branding for showing dedication, leadership and overall excellence in finance management.

The world’s leading international personal branding organization which has its U.S. headquarters in Wayne honored Miller for her professional efforts and accomplishments.

Miller is responsible for forecasting the company’s finances and also for helping map out its overall strategy. She also ensures that escrow accounts for liability and bank balances are accurate and oversees all transactions in relation to the general ledger, receivables, payables, payroll, and financial reporting.

A holder of a Bachelor of Science in Accounting from West Chester University, Miller became a member of AMA and ACT and went on to receive a Distinguished Services Awards for the Company Purchase of Clinical Financial Services from DrugDev in 2014. She has also earned Value of Distinction Awards in 2013 and 2015.

The endorsement also has other benefits, as Miller has been added to Worldwide Branding’s distinguished Registry of Executives, Professionals and Entrepreneurs. This makes Miller one of a select few of Worldwide Branding members that are endorsed and promoted as leaders in their respective professional fields.

Advertisement